Onivyde (irinotecan, liposomal formulations): reports of serious and fatal thromboembolic events

2019-03-21T11:49:57+00:00

Onivyde has been associated with reports of serious thromboembolic events, such as pulmonary embolism, venous thrombosis, and arterial thromboembolism.